牙周炎通过PD-1/PD-L1促进瘤生长和免疫逃避
Suli Wang1, Fujiao Nie1, Qiuyue Yin1
1Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, No. 44-1 Wenhua Road West, 250012, Jinan, Shandong, China.
Cancer immunology, immunotherapy : CII
|November 13, 2024
概括
实验性牙周炎通过增加免疫抑制细胞和PD-1/PD-L1表达来促进口腔癌的生长. 抗PD-1疗法可以减少这些影响,这表明牙疾病和癌症进展之间存在联系.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 口腔医学是指口腔医学.
背景情况:
- 研究实验性牙周炎对瘤生长的影响.
- 检查口腔状细胞癌 (OSCC) 和前列腺癌的局部和全身免疫抑制.
- 在癌症模型中评估编程死亡受体1 (PD-1) 和编程死亡连接体1 (PD-L1) 的表达.
研究的目的:
- 确定牙周炎如何影响瘤进展.
- 分析免疫细胞群和PD-1/PD-L1表达的变化.
- 在牙周炎相关癌症模型中评估抗PD-1疗法的疗效.
主要方法:
- 用于口腔和前列腺癌的老鼠异种移植模型.
- 采用流细胞计和免疫光检测检测免疫细胞.
- 在体外和人类OSCC样本中分析了PD-L1表达.
主要成果:
- 牙周炎显著增加了瘤体积和体重.
- 观察到瘤相关巨细胞 (TAMs),调节性T细胞 (Tregs) 和PD-1/PD-L1表达的增加.
- 发现抗PD-1疗法减弱了牙周炎的瘤促进作用.
结论:
- 牙周炎可能会增强瘤生长和免疫逃避.
- 增加免疫抑制细胞和PD-1/PD-L1表达是关键机制.
- 向PD-1/PD-L1通路可能有助于治疗牙周炎相关的癌症.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Psychoneuroimmunology: Diabetes and Cancer
24
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


